Literature DB >> 23458325

The disappearance of onchocerciasis from the Itwara focus, western Uganda after elimination of the vector Simulium neavei and 19 years of annual ivermectin treatments.

T L Lakwo1, R Garms, T Rubaale, M Katabarwa, F Walsh, P Habomugisha, D Oguttu, T Unnasch, H Namanya, E Tukesiga, J Katamanywa, J Bamuhiiga, E Byamukama, S Agunyo, F Richards.   

Abstract

The Itwara onchocerciasis focus is located around the Itwara forest reserve in western Uganda. In 1991, annual treatments with ivermectin started in the focus. They were supplemented in 1995 by the control of the vector Simulium neavei, which was subsequently eliminated from the focus. The impact of the two interventions on the disease was assessed in 2010 by nodule palpations, examinations of skin snips by microscopy and PCR, and Ov16 recombinant ELISA. There was no evidence of any microfilaria in 688 skin snips and only 2 (0.06%) of 3316 children examined for IgG4 were slightly above the arbitrary cut off of 40. A follow up of the same children 21 months later in 2012 confirmed that both were negative for diagnostic antigen Ov-16, skin snip microscopy and PCR. Based on the World Health Organization (WHO) elimination criteria of 2001 and the Uganda onchocerciasis certification guidelines, it was concluded that the disease has disappeared from the Itwara focus after 19 years of ivermectin treatments and the elimination of the vector around 2001. Ivermectin treatments were recommended to be halted.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23458325     DOI: 10.1016/j.actatropica.2013.02.016

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  28 in total

1.  Serosurveillance to monitor onchocerciasis elimination: the Ugandan experience.

Authors:  David Oguttu; Edson Byamukama; Charles R Katholi; Peace Habomugisha; Christine Nahabwe; Monica Ngabirano; Hassan K Hassan; Thomson Lakwo; Moses Katabarwa; Frank O Richards; Thomas R Unnasch
Journal:  Am J Trop Med Hyg       Date:  2013-12-16       Impact factor: 2.345

2.  Assessments of the transmission of Onchocerca volvulus by Simulium sanctipauli in the Upper Denkyira District, Ghana, and the intermittent disappearance of the vector.

Authors:  R Garms; K Badu; E Owusu-Dabo; S Baffour-Awuah; O Adjei; A Y Debrah; M Nagel; N K Biritwum; L Gankpala; R J Post; T F Kruppa
Journal:  Parasitol Res       Date:  2015-01-17       Impact factor: 2.289

3.  Operational Performance of the Onchocerca volvulus "OEPA" Ov16 ELISA Serological Assay in Mapping, Guiding Decisions to Stop Mass Drug Administration, and Posttreatment Surveillance Surveys.

Authors:  Frank O Richards; Moses Katabarwa; Firdaweke Bekele; Zerihun Tadesse; Aderajew Mohammed; Mauricio Sauerbrey; Alfredo Dominguez-Vazquez; Mario A Rodriguez-Perez; Nadia A Fernández-Santos; Nidia Rizzo; Harland R Schuler Martínez; Raquel Lovato Silva; Zoraida Morales Monroy; Peace Habomugisha; David W Oguttu; Issam M A Zarroug; Nabil A Aziz; Thomas R Unnasch
Journal:  Am J Trop Med Hyg       Date:  2018-07-12       Impact factor: 2.345

Review 4.  Natural Products That Changed Society.

Authors:  Søren Brøgger Christensen
Journal:  Biomedicines       Date:  2021-04-26

5.  Evaluation of Community-Directed Operation of Black Fly Traps for Entomological Surveillance of Onchocerca volvulus Transmission in the Madi-Mid North Focus of Onchocerciasis in Northern Uganda.

Authors:  Denis Loum; Charles R Katholi; Thomson Lakwo; Peace Habomugisha; Edridah M Tukahebwa; Thomas R Unnasch
Journal:  Am J Trop Med Hyg       Date:  2017-10       Impact factor: 3.707

6.  Ongoing Transmission of Onchocerca volvulus after 25 Years of Annual Ivermectin Mass Treatments in the Vina du Nord River Valley, in North Cameroon.

Authors:  Albert Eisenbarth; Mbunkah Daniel Achukwi; Alfons Renz
Journal:  PLoS Negl Trop Dis       Date:  2016-02-29

7.  Evaluation of onchocerciasis seroprevalence in Bioko Island (Equatorial Guinea) after years of disease control programmes.

Authors:  Ana Hernández-González; Laura Moya; María J Perteguer; Zaida Herrador; Rufino Nguema; Justino Nguema; Pilar Aparicio; Agustín Benito; Teresa Gárate
Journal:  Parasit Vectors       Date:  2016-09-20       Impact factor: 3.876

8.  Outstanding insecurities concerning the use of an Ov16-based ELISA in the Amazonia onchocerciasis focus.

Authors:  Sérgio Luiz Bessa Luz; James Lee Crainey; Anthony John Shelley; Miguel Rubio
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-07       Impact factor: 2.743

9.  The Imaramagambo Onchocerciasis Focus in Southwestern Uganda: Interruption of Transmission After Disappearance of the Vector Simulium neavei and Its Associated Freshwater Crabs.

Authors:  Moses N Katabarwa; James Katamanywa; Thomson Lakwo; Peace Habomugisha; Edson Byamukama; David Oguttu; Christine Nahabwe; Monica Ngabirano; Ephraim Tukesiga; Annet Khainza; Edridah Tukahebwa; Thomas R Unnasch; Frank O Richards; Rolf Garms
Journal:  Am J Trop Med Hyg       Date:  2016-05-23       Impact factor: 2.345

10.  Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis.

Authors:  Allison Golden; Dunia Faulx; Michael Kalnoky; Eric Stevens; Lindsay Yokobe; Roger Peck; Potochoziou Karabou; Méba Banla; Ramakrishna Rao; Kangi Adade; Richard G Gantin; Kossi Komlan; Peter T Soboslay; Tala de Los Santos; Gonzalo J Domingo
Journal:  Parasit Vectors       Date:  2016-06-13       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.